Intra-Cellular Therapies Announces Expansion of its Pipeline with the Introduction of a New Molecular Entity, ITI-1284

Go back to Intra-Cellular Therapies Announces Expansion of its Pipeline with the Introduction of a New Molecular Entity, ITI-1284
INTRA-CELL THRP (NASDAQ: ITCI) Delayed: 35.03 +1.60 (4.79%)
Previous Close $33.43    52 Week High $59.96 
Open $33.85    52 Week Low $10.80 
Day High $35.07    P/E N/A 
Day Low $33.44    EPS $0.00 
Volume 526,391